INNOVATION PHARMACEUTICALS INC. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ef39d927-9091-4899-971b-9a47d5d81f0c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $0 | 2022-07-01 – 2023-06-30 | evidence 0001477932-23-007158 |
| FY 2022 | $18.0k | 2021-07-01 – 2022-06-30 | evidence 0001477932-22-007292 |
| FY 2021 | $0 | 2020-07-01 – 2021-06-30 | evidence 0001477932-21-006717 |
| FY 2020 | $423.0k | 2019-07-01 – 2020-06-30 | evidence 0001477932-20-005387 |
| FY 2019 | $0 | 2018-07-01 – 2019-06-30 | evidence 0001477932-20-005387 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INNOVATION PHARMACEUTICALS INC. — all facts · Net Income · Operating Income